Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2499

TDMS Study 05079-01 Pathology Tables



                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                                TALC


NTP Experiment-Test: 05079-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/10/94
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44




       Facility:  Lovelace Inhalation Toxicology Research Institute

       Chemical CAS #:  14807966

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           22           50           22           50           22           
  Scheduled Sacrifice                                              14                        18                        12           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                28            5           17            3           27            8           
    Natural Death                                     11            2           19            1           14            2           
  Survivors                                                                                                                         
    Terminal Sacrifice                                11            1           13                         9                        
  Missing                                                                        1                                                  
  Animals Examined Microscopically                    50           15           49           18           50           12           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (46)         (15)         (34)         (18)         (43)         (12)         
      Hemorrhage, Focal                                                          1 (3%)                                             
      Inflammation                                    11 (24%)                   1 (3%)                    6 (14%)                  
      Parasite Metazoan                                7 (15%)      2 (13%)      3 (9%)       6 (33%)      6 (14%)      4 (33%)     
      Ulcer                                            1 (2%)                    1 (3%)                    1 (2%)                   
   Intestine Large, Colon                             (48)         (15)         (41)         (18)         (45)         (12)         
      Inflammation                                                               1 (2%)                    2 (4%)                   
      Parasite Metazoan                                2 (4%)       2 (13%)      3 (7%)                    3 (7%)       1 (8%)      
   Intestine Large, Rectum                            (38)         (15)         (37)         (18)         (41)         (12)         
      Inflammation                                     4 (11%)                                                                      
      Parasite Metazoan                                2 (5%)                    1 (3%)                    1 (2%)                   
   Intestine Small, Duodenum                          (48)         (15)         (44)         (18)         (47)         (12)         
      Necrosis, Focal                                  1 (2%)                                                                       
   Intestine Small, Ileum                             (44)         (15)         (32)         (18)         (38)         (12)         
      Hyperplasia, Lymphoid                            2 (5%)                                                                       
   Liver                                              (50)         (15)         (48)         (18)         (50)         (12)         
      Atrophy                                                                    1 (2%)                    1 (2%)                   
      Basophilic Focus                                27 (54%)      2 (13%)     17 (35%)      4 (22%)     21 (42%)      2 (17%)     
      Clear Cell Focus                                 1 (2%)                    2 (4%)                    1 (2%)                   
      Cyst Multilocular                                1 (2%)                                                                       
      Degeneration, Cystic                                                       2 (4%)                    1 (2%)                   
      Eosinophilic Focus                               2 (4%)       2 (13%)      5 (10%)                   4 (8%)                   
      Fatty Change                                    18 (36%)      1 (7%)      18 (38%)      1 (6%)      14 (28%)                  
      Fibrosis, Focal                                                                                                   1 (8%)      
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hyperplasia                                                   1 (7%)                                                          
      Infiltration Cellular, Mononuclear Cell                                                              1 (2%)                   
      Inflammation, Chronic                                         1 (7%)                    1 (6%)                    1 (8%)      
      Inflammation, Focal, Granulomatous              13 (26%)                   3 (6%)                    4 (8%)                   
      Inflammation, Focal, Necrotizing                                           1 (2%)                                             
      Inflammation, Suppurative                        1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Necrosis, Focal                                  5 (10%)                   1 (2%)                    2 (4%)                   
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Thrombosis                                                                                           1 (2%)                   
      Bile Duct, Hyperplasia                          36 (72%)      7 (47%)     38 (79%)      8 (44%)     36 (72%)      4 (33%)     
      Centrilobular, Atrophy                                                     2 (4%)                    6 (12%)                  
      Centrilobular, Degeneration                     10 (20%)                  14 (29%)                  10 (20%)                  
      Centrilobular, Necrosis                          2 (4%)                    2 (4%)                    2 (4%)                   
      Hepatocyte, Atrophy, Focal                                                                           1 (2%)                   
      Serosa, Thrombosis                                                         3 (6%)                                             
   Mesentery                                          (1)                       (2)                                                 
      Granuloma                                        1 (100%)                  1 (50%)                                            
      Inflammation, Chronic Active                                               1 (50%)                                            
   Pancreas                                           (50)         (15)         (46)         (18)         (49)         (12)         
      Hyperplasia, Nodular                             1 (2%)                                                                       
      Inflammation                                                               1 (2%)       1 (6%)                                
      Lobules, Atrophy                                 7 (14%)      1 (7%)       7 (15%)                   9 (18%)                  
   Salivary Glands                                    (50)         (15)         (48)         (18)         (50)         (12)         
      Inflammation                                     2 (4%)                                                                       
   Stomach, Forestomach                               (50)         (15)         (45)         (17)         (49)         (12)         
      Hyperkeratosis                                   1 (2%)                                              1 (2%)                   
      Hyperplasia, Squamous                                                                   1 (6%)                                
      Inflammation                                     1 (2%)                                              2 (4%)                   
      Mineralization                                                             1 (2%)                                             
      Ulcer                                            9 (18%)                   4 (9%)                    3 (6%)                   
   Stomach, Glandular                                 (50)         (15)         (47)         (17)         (50)         (12)         
      Erosion                                                                                              1 (2%)                   
      Inflammation                                     1 (2%)                    1 (2%)                                             
      Mineralization                                   2 (4%)                    2 (4%)                    2 (4%)                   
      Ulcer                                            3 (6%)                    2 (4%)                    3 (6%)                   
      Ulcer, Multiple                                  1 (2%)                                              1 (2%)                   
      Arteriole, Muscularis, Lamina Propria,                                                                                        
          Mineralization                                                         1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (3)                       (3)                       (1)                       
      Aorta, Mineralization                                                      3 (100%)                  1 (100%)                 
      Mesenteric Artery, Aneurysm                      1 (33%)                                                                      
      Mesenteric Artery, Inflammation                  3 (100%)                                                                     
      Mesenteric Artery, Mineralization                                          1 (33%)                   1 (100%)                 
      Mesenteric Artery, Thrombosis                    1 (33%)                   1 (33%)                                            
   Heart                                              (50)         (15)         (48)         (18)         (50)         (12)         
      Cardiomyopathy                                  35 (70%)      6 (40%)     40 (83%)      8 (44%)     36 (72%)      3 (25%)     
      Inflammation, Focal                              1 (2%)                                              1 (2%)                   
      Atrium, Thrombosis                               5 (10%)                   8 (17%)                   5 (10%)                  
      Myocardium, Embolus                                                        2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Myocardium, Inflammation, Focal                                            1 (2%)                                             
      Myocardium, Mineralization                       1 (2%)                    4 (8%)                    3 (6%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (14)         (47)         (16)         (49)         (12)         
      Congestion                                                    1 (7%)                    1 (6%)                                
      Degeneration, Cystic                             1 (2%)       1 (7%)                                                          
      Degeneration, Fatty                              3 (6%)                                 1 (6%)                                
      Degeneration, Focal                              1 (2%)                    1 (2%)                                             
      Hyperplasia, Diffuse                                                       1 (2%)                    1 (2%)                   
      Hyperplasia, Focal                               9 (18%)                  12 (26%)                  13 (27%)                  
      Necrosis                                                                                             2 (4%)                   
      Necrosis, Focal                                  1 (2%)                    1 (2%)                                             
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Vacuolization Cytoplasmic                                     1 (7%)                                                          
   Adrenal Gland, Medulla                             (48)         (14)         (47)         (18)         (49)         (11)         
      Cyst                                             1 (2%)                                                                       
      Hyperplasia                                     20 (42%)      3 (21%)     18 (38%)      1 (6%)      14 (29%)      1 (9%)      
      Bilateral, Hyperplasia                           2 (4%)                    2 (4%)                    2 (4%)                   
   Parathyroid Gland                                  (43)         (12)         (42)         (15)         (47)         (8)          
      Cyst                                                                                    1 (7%)                                
      Hyperplasia                                      3 (7%)                    4 (10%)                   2 (4%)                   
      Bilateral, Hyperplasia                           1 (2%)                                                                       
   Pituitary Gland                                    (50)         (15)         (47)         (18)         (50)         (12)         
      Cyst                                             2 (4%)                                 1 (6%)       1 (2%)                   
      Pars Distalis, Hyperplasia                      10 (20%)                   6 (13%)                   4 (8%)       1 (8%)      
      Pars Distalis, Necrosis                                                                              1 (2%)                   
   Thyroid Gland                                      (50)         (13)         (47)         (18)         (49)         (11)         
      C-Cell, Hyperplasia                             10 (20%)      4 (31%)      8 (17%)      2 (11%)      4 (8%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (47)         (15)         (44)         (16)         (46)         (12)         
      Fibrosis                                                                                1 (6%)                                
      Hyperplasia                                      2 (4%)                                              1 (2%)                   
      Inflammation                                     1 (2%)                    1 (2%)                    1 (2%)                   
   Ovary                                              (50)         (15)         (47)         (18)         (50)         (12)         
      Cyst                                             5 (10%)      1 (7%)                                 1 (2%)                   
   Uterus                                             (50)         (15)         (48)         (18)         (50)         (12)         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Cyst                                             1 (2%)                    1 (2%)                    1 (2%)                   
      Hyperplasia, Cystic                                                                     1 (6%)                                
      Inflammation                                     1 (2%)                    1 (2%)                                             
      Endometrium, Hyperplasia                         3 (6%)                                                                       
      Lamina Propria, Fibrosis                        20 (40%)                  39 (81%)                  19 (38%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (15)         (43)         (18)         (49)         (12)         
      Atrophy                                          1 (2%)                    2 (5%)                    1 (2%)                   
      Hyperplasia, Histiocytic                         1 (2%)       1 (7%)                    2 (11%)      1 (2%)       2 (17%)     
      Inflammation, Focal, Granulomatous               1 (2%)                                                                       
      Myelofibrosis                                    1 (2%)                    3 (7%)                    3 (6%)                   
      Necrosis, Focal                                                            1 (2%)                                             
      Femoral, Hyperplasia, Histiocytic                                                       1 (6%)                                
      Myeloid Cell, Hyperplasia                        2 (4%)                    2 (5%)       1 (6%)       3 (6%)       1 (8%)      
   Lymph Node                                         (50)         (15)         (48)         (18)         (50)         (12)         
      Axillary, Hemorrhage, Chronic                                                                        1 (2%)                   
      Renal, Hyperplasia, Histiocytic                                                         1 (6%)                                
   Lymph Node, Bronchial                              (46)         (10)         (47)         (18)         (47)         (9)          
      Cyst                                             1 (2%)                                                                       
      Fibrosis                                                                   1 (2%)                                             
      Hemorrhage, Chronic                                                        1 (2%)                                             
      Hyperplasia, Histiocytic                                                  40 (85%)     18 (100%)    45 (96%)      8 (89%)     
      Hyperplasia, Lymphoid                                         1 (10%)                                                         
      Inflammation, Suppurative                        1 (2%)                                                                       
      Pigmentation, Hemosiderin                        1 (2%)       1 (10%)                                                         
   Lymph Node, Mandibular                             (47)         (9)          (46)         (14)         (47)         (11)         
      Congestion                                                                                                        1 (9%)      
      Hyperplasia, Lymphoid                                                      1 (2%)       2 (14%)      1 (2%)       1 (9%)      
      Hyperplasia, Plasma Cell                         2 (4%)                    1 (2%)                    1 (2%)                   
      Inflammation, Chronic Active                     1 (2%)                                              1 (2%)                   
      Inflammation, Suppurative                                                                            1 (2%)                   
   Lymph Node, Mediastinal                            (47)         (11)         (44)         (17)         (47)         (12)         
      Congestion                                                    2 (18%)                   1 (6%)                    1 (8%)      
      Hemorrhage, Chronic                              1 (2%)                                                                       
      Hyperplasia, Histiocytic                                                  33 (75%)     14 (82%)     40 (85%)      9 (75%)     
      Hyperplasia, Lymphoid                            1 (2%)                                              1 (2%)                   
      Inflammation, Chronic Active                                                                         1 (2%)                   
      Inflammation, Suppurative                        1 (2%)                    1 (2%)                                             
      Pigmentation, Hemosiderin                                     2 (18%)                                                         
   Lymph Node, Mesenteric                             (49)         (14)         (47)         (18)         (47)         (12)         
      Edema                                                                                   1 (6%)                                
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia, Histiocytic                                      1 (7%)                    1 (6%)                                
      Hyperplasia, Lymphoid                            2 (4%)                    1 (2%)       1 (6%)       2 (4%)                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hyperplasia, Plasma Cell                         1 (2%)                                                                       
      Inflammation, Chronic Active                     4 (8%)                    1 (2%)                                             
      Inflammation, Granulomatous                                                                          1 (2%)                   
   Spleen                                             (50)         (15)         (48)         (18)         (50)         (12)         
      Atrophy                                          2 (4%)                    2 (4%)                    2 (4%)                   
      Fibrosis, Focal                                  3 (6%)                    1 (2%)                    1 (2%)                   
      Hematopoietic Cell Proliferation                 4 (8%)                    6 (13%)      1 (6%)       7 (14%)                  
      Hyperplasia, Lymphoid                                                                                1 (2%)                   
      Inflammation, Focal, Granulomatous               1 (2%)                                                                       
      Pigmentation, Hemosiderin                        2 (4%)                                                                       
      Capsule, Hemorrhage                                                                                  1 (2%)                   
   Thymus                                             (47)         (14)         (44)         (15)         (47)         (12)         
      Cyst                                                                                    1 (7%)                                
      Inflammation                                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (15)         (48)         (18)         (50)         (12)         
      Galactocele                                                                1 (2%)                                             
      Hyperplasia, Cystic                                           2 (13%)      2 (4%)       1 (6%)                                
      Lobules, Hyperplasia                                          2 (13%)                                1 (2%)                   
   Skin                                               (50)         (15)         (49)         (18)         (50)         (12)         
      Inflammation, Focal                              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (15)         (48)         (18)         (50)         (12)         
      Fibrous Osteodystrophy                           4 (8%)                    3 (6%)                    4 (8%)                   
      Hyperostosis                                     4 (8%)                    1 (2%)                    3 (6%)                   
      Femur, Hyperplasia                                            1 (7%)                                                          
      Pelvis, Fracture                                 1 (2%)                                                                       
      Vertebra, Cyst                                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (15)         (48)         (18)         (50)         (12)         
      Compression                                      8 (16%)      1 (7%)       7 (15%)                   9 (18%)                  
      Hemorrhage                                                                 1 (2%)                    1 (2%)                   
      Hydrocephalus                                                                                        1 (2%)                   
      Inflammation, Focal                                                        1 (2%)                                             
      White Matter, Necrosis, Focal                                                                        2 (4%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (15)         (48)         (18)         (48)         (12)         
      Inflammation, Necrotizing                                                                            1 (2%)                   
      Inflammation, Suppurative                        2 (4%)                    1 (2%)                    1 (2%)                   
   Lung                                               (50)         (15)         (48)         (18)         (50)         (12)         
      Crystals, Focal                                  1 (2%)                                                                       
      Cyst                                                                       1 (2%)                    5 (10%)                  
      Cyst, Multiple                                                                                       2 (4%)                   
      Edema                                            1 (2%)                                                                       
      Hemorrhage                                                                 1 (2%)                    1 (2%)                   
      Hyperplasia, Diffuse, Adenomatous                                                                    2 (4%)                   
      Inflammation, Chronic Active                                  1 (7%)                                                          
      Inflammation, Granulomatous                      2 (4%)       1 (7%)      47 (98%)     18 (100%)    50 (100%)    12 (100%)    
      Inflammation, Suppurative                        2 (4%)                    1 (2%)                                             
      Mineralization                                                             2 (4%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (4%)       2 (13%)     27 (56%)     16 (89%)     47 (94%)     10 (83%)     
      Alveolus, Metaplasia, Squamous                                                                       8 (16%)                  
      Bronchus, Epithelium, Degeneration, Focal        1 (2%)                                                                       
      Interstitium, Fibrosis                                                                               1 (2%)                   
      Interstitium, Fibrosis, Focal                    1 (2%)                   24 (50%)     13 (72%)     44 (88%)      9 (75%)     
      Interstitium, Mineralization                                               1 (2%)                    1 (2%)                   
      Peribronchial, Hyperplasia, Histiocytic                                    8 (17%)      5 (28%)      9 (18%)      6 (50%)     
   Nose                                               (48)         (15)         (45)         (18)         (48)         (12)         
      Inflammation, Suppurative                                                  1 (2%)                                             
      Lumen, Foreign Body                                                                                  1 (2%)                   
      Mucosa, Inflammation, Suppurative                                          3 (7%)                    5 (10%)                  
      Nasolacrimal Duct, Inflammation, Suppurative     1 (2%)                                                                       
      Nerve, Developmental Malformation                1 (2%)                                                                       
      Olfactory Epithelium, Metaplasia                                           1 (2%)                                             
      Respiratory Epithelium, Hyperplasia              1 (2%)                    1 (2%)                    2 (4%)                   
      Respiratory Epithelium, Metaplasia, Squamous                               1 (2%)                                             
   Trachea                                            (50)         (15)         (48)         (18)         (50)         (12)         
      Inflammation, Necrotizing                                                                            1 (2%)                   
      Inflammation, Suppurative                        3 (6%)                    1 (2%)                    2 (4%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)                                                 (2)                       
      Cataract                                         2 (100%)                                            2 (100%)                 
      Retina, Degeneration                             2 (100%)                                            2 (100%)                 
   Harderian Gland                                    (5)                       (7)          (1)          (15)                      
      Inflammation                                     4 (80%)                   3 (43%)                   3 (20%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (15)         (47)         (18)         (49)         (12)         
      Abscess                                          1 (2%)                                                                       
      Cyst                                                                       1 (2%)                    1 (2%)                   
      Cyst, Multiple                                   1 (2%)                                                                       
      Embolus, Multiple                                                          1 (2%)                                             
      Infarct                                          1 (2%)                                                                       
      Infarct, Multiple                                                                                    1 (2%)                   
      Inflammation                                     1 (2%)                    1 (2%)                                             
      Nephropathy                                     44 (90%)      9 (60%)     43 (91%)     12 (67%)     42 (86%)      6 (50%)     
      Capsule, Inflammation                                                      1 (2%)                                             
      Medulla, Inflammation                                                      1 (2%)                    1 (2%)                   
      Renal Tubule, Necrosis                           1 (2%)                                              2 (4%)                   
   Urinary Bladder                                    (50)         (15)         (45)         (18)         (50)         (12)         
      Inflammation                                                                                         1 (2%)                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           22           50           22           50           22           
  Scheduled Sacrifice                                              11                        15                        10           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                23            9           19            5           20            6           
    Natural Death                                     18            2           17            2           14            6           
  Survivors                                                                                                                         
    Terminal Sacrifice                                                           1                                                  
    Terminal Sacrifice                                 8                        11                        13                        
    Natural Death                                      1                         2                         3                        
  Animals Examined Microscopically                    49           11           50           15           50           10           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (49)         (10)         (50)         (10)         (49)         (9)          
      Inflammation                                                                                         1 (2%)                   
   Intestine Large, Cecum                             (42)         (11)         (38)         (15)         (37)         (10)         
      Hemorrhage                                                                 1 (3%)                                             
      Inflammation                                     9 (21%)                   2 (5%)                    5 (14%)                  
      Parasite Metazoan                                3 (7%)       4 (36%)      4 (11%)      6 (40%)      4 (11%)      4 (40%)     
      Ulcer                                            1 (2%)                                                                       
   Intestine Large, Colon                             (43)         (11)         (43)         (15)         (46)         (10)         
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Inflammation                                     1 (2%)                                              1 (2%)                   
      Mineralization                                                                                       1 (2%)                   
      Parasite Metazoan                                2 (5%)       1 (9%)       1 (2%)       1 (7%)       1 (2%)                   
   Intestine Large, Rectum                            (38)         (11)         (41)         (15)         (34)         (10)         
      Inflammation                                     6 (16%)                   1 (2%)                    1 (3%)                   
      Metaplasia, Focal, Squamous                                                                          1 (3%)                   
      Parasite Metazoan                                             1 (9%)       2 (5%)                                             
   Intestine Small, Duodenum                          (48)         (11)         (44)         (15)         (46)         (10)         
      Inflammation                                                                                         1 (2%)                   
      Mineralization                                   1 (2%)                                                                       
      Necrosis, Focal                                  1 (2%)                                                                       
      Ulcer                                            1 (2%)                    1 (2%)                                             
   Intestine Small, Ileum                             (39)         (11)         (34)         (15)         (35)         (10)         
      Hyperplasia, Lymphoid                                                      1 (3%)                    2 (6%)                   
      Lymphatic, Ectasia                                                         1 (3%)                                             
      Peyer's Patch, Hyperplasia, Focal, Lymphoid                                             1 (7%)                                
   Liver                                              (49)         (11)         (50)         (15)         (48)         (10)         
      Angiectasis, Focal                               1 (2%)                                                                       
      Atrophy                                          1 (2%)                                                                       
      Basophilic Focus                                18 (37%)      2 (18%)     18 (36%)      4 (27%)     19 (40%)      4 (40%)     
      Clear Cell Focus                                 3 (6%)                    7 (14%)                   4 (8%)                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Congestion                                                                 1 (2%)                                 1 (10%)     
      Degeneration, Cystic                             9 (18%)                  17 (34%)                   9 (19%)                  
      Degeneration, Diffuse                                                                                1 (2%)                   
      Eosinophilic Focus                               2 (4%)                    7 (14%)                   7 (15%)                  
      Fatty Change                                    16 (33%)      1 (9%)      14 (28%)                  12 (25%)                  
      Fibrosis                                         1 (2%)                                                                       
      Hematocyst                                                                 1 (2%)                                             
      Hyperplasia, Focal                                            1 (9%)                                 1 (2%)                   
      Inflammation, Focal, Granulomatous               3 (6%)                    1 (2%)                                             
      Inflammation, Focal, Necrotizing                                                                     1 (2%)                   
      Inflammation, Focal, Subacute                                                           1 (7%)                                
      Necrosis, Coagulative, Multifocal                             1 (9%)                                                          
      Necrosis, Focal                                  3 (6%)                                              1 (2%)                   
      Thrombosis                                       1 (2%)       1 (9%)                                                          
      Bile Duct, Hyperplasia                          39 (80%)      5 (45%)     46 (92%)      9 (60%)     44 (92%)      3 (30%)     
      Centrilobular, Atrophy                           9 (18%)                   4 (8%)                    7 (15%)                  
      Centrilobular, Degeneration                      8 (16%)                  12 (24%)                   9 (19%)                  
      Centrilobular, Degeneration, Fatty                                                                   1 (2%)                   
      Centrilobular, Necrosis                          5 (10%)                                             2 (4%)                   
   Mesentery                                          (2)                                                 (1)                       
      Inflammation                                                                                         1 (100%)                 
   Pancreas                                           (48)         (11)         (46)         (15)         (47)         (10)         
      Lobules, Atrophy                                11 (23%)                   7 (15%)                   8 (17%)                  
   Salivary Glands                                    (49)         (11)         (50)         (15)         (50)         (10)         
      Inflammation                                     1 (2%)                                                                       
      Necrosis                                                                                             1 (2%)                   
   Stomach, Forestomach                               (49)         (10)         (47)         (15)         (47)         (10)         
      Hyperkeratosis                                                                                       1 (2%)                   
      Inflammation                                     1 (2%)                                                                       
      Mineralization                                   1 (2%)                    4 (9%)                    1 (2%)                   
      Ulcer                                            5 (10%)                   5 (11%)                   8 (17%)                  
   Stomach, Glandular                                 (49)         (10)         (47)         (15)         (47)         (10)         
      Mineralization                                   6 (12%)                   6 (13%)                   6 (13%)                  
      Ulcer                                            3 (6%)                    3 (6%)                    2 (4%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (4)                       (5)                       (5)                       
      Aorta, Mineralization                            3 (75%)                   5 (100%)                  4 (80%)                  
      Mesenteric Artery, Aneurysm                                                                          2 (40%)                  
      Mesenteric Artery, Inflammation                                                                      1 (20%)                  
      Mesenteric Artery, Mineralization                3 (75%)                   5 (100%)                  3 (60%)                  
      Mesenteric Artery, Thrombosis                    1 (25%)                   1 (20%)                   1 (20%)                  
   Heart                                              (49)         (11)         (50)         (15)         (50)         (10)         
      Cardiomyopathy                                  42 (86%)      6 (55%)     47 (94%)      8 (53%)     50 (100%)     3 (30%)     
      Atrium, Thrombosis                               9 (18%)                   5 (10%)                  11 (22%)                  
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Epicardium, Hyperplasia                          1 (2%)                                                                       
      Myocardium, Inflammation                                                   1 (2%)                                             
      Myocardium, Mineralization                       2 (4%)                    6 (12%)                   5 (10%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (49)         (11)         (49)         (15)         (48)         (10)         
      Degeneration                                     1 (2%)                                                                       
      Degeneration, Fatty                              8 (16%)                                             2 (4%)                   
      Degeneration, Focal                              1 (2%)                                                                       
      Hyperplasia, Diffuse                                                                                 2 (4%)                   
      Hyperplasia, Focal                              11 (22%)                   4 (8%)       1 (7%)       9 (19%)                  
      Necrosis, Focal                                  1 (2%)                                                                       
   Adrenal Gland, Medulla                             (49)         (10)         (48)         (15)         (47)         (10)         
      Hyperplasia                                     19 (39%)      1 (10%)      8 (17%)      3 (20%)      8 (17%)                  
      Bilateral, Hyperplasia                           1 (2%)       1 (10%)                                1 (2%)                   
   Islets, Pancreatic                                 (47)         (9)          (41)         (15)         (43)         (10)         
      Hyperplasia                                                                             1 (7%)       1 (2%)                   
   Parathyroid Gland                                  (45)         (6)          (45)         (7)          (46)         (8)          
      Hyperplasia                                      6 (13%)      1 (17%)     11 (24%)                  12 (26%)                  
      Bilateral, Hyperplasia                           1 (2%)                                                                       
   Pituitary Gland                                    (47)         (11)         (50)         (14)         (49)         (10)         
      Angiectasis, Focal                                                         1 (2%)                                             
      Cyst                                                                       1 (2%)       1 (7%)       1 (2%)       1 (10%)     
      Pars Distalis, Hyperplasia                       8 (17%)      1 (9%)       8 (16%)                   7 (14%)                  
      Pars Nervosa, Hyperplasia                                                  1 (2%)                                             
   Thyroid Gland                                      (45)         (11)         (46)         (13)         (46)         (8)          
      C-Cell, Hyperplasia                              5 (11%)      1 (9%)       7 (15%)      2 (15%)      2 (4%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (9)          (50)         (15)         (49)         (10)         
      Spermatocele                                                               1 (2%)                                             
   Preputial Gland                                    (48)         (11)         (49)         (15)         (48)         (8)          
      Hyperplasia                                      3 (6%)                                              1 (2%)                   
      Inflammation                                     7 (15%)                   2 (4%)                    5 (10%)                  
   Prostate                                           (49)         (10)         (45)         (15)         (48)         (10)         
      Atrophy                                          1 (2%)                                              1 (2%)                   
      Inflammation                                    22 (45%)      1 (10%)     14 (31%)      1 (7%)      19 (40%)      1 (10%)     
   Seminal Vesicle                                    (49)         (11)         (48)         (15)         (47)         (10)         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Atrophy                                          1 (2%)                                                                       
      Inflammation                                     1 (2%)                                                                       
   Testes                                             (49)         (11)         (50)         (15)         (50)         (10)         
      Atrophy                                         14 (29%)                  11 (22%)      1 (7%)      16 (32%)      1 (10%)     
      Cyst                                                          1 (9%)                                                          
      Hyperplasia, Focal, Lymphoid                                                                         1 (2%)                   
      Hyperplasia, Lymphoid                                                      2 (4%)                                             
      Interstitial Cell, Hyperplasia                   2 (4%)                    1 (2%)       1 (7%)       3 (6%)                   
      Serosa, Proliferation                                                                                1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (48)         (11)         (48)         (15)         (47)         (10)         
      Atrophy                                                                                              2 (4%)                   
      Atrophy, Focal                                                             1 (2%)                                             
      Hyperplasia, Histiocytic                                                                2 (13%)                               
      Inflammation                                                               1 (2%)                                             
      Myelofibrosis                                                              1 (2%)                    1 (2%)                   
      Myeloid Cell, Hyperplasia                        2 (4%)       1 (9%)       3 (6%)                    6 (13%)                  
   Lymph Node                                         (49)         (11)         (50)         (15)         (50)         (10)         
      Hemorrhage, Chronic                                                        1 (2%)                                             
      Pancreatic, Atrophy                              1 (2%)                                                                       
      Pancreatic, Hyperplasia, Lymphoid                1 (2%)                                                                       
   Lymph Node, Bronchial                              (41)         (9)          (48)         (15)         (49)         (10)         
      Atrophy                                          2 (5%)                                                                       
      Hemorrhage                                                                 1 (2%)                                             
      Hemorrhage, Acute                                1 (2%)                                                                       
      Hemorrhage, Chronic                              4 (10%)                                                                      
      Hyperplasia, Histiocytic                                                  44 (92%)     12 (80%)     46 (94%)     10 (100%)    
   Lymph Node, Mandibular                             (46)         (10)         (48)         (12)         (47)         (9)          
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                                         1 (10%)      2 (4%)       1 (8%)                    1 (11%)     
      Hyperplasia, Plasma Cell                                                   2 (4%)                    5 (11%)                  
      Inflammation, Chronic Active                                                                         2 (4%)                   
   Lymph Node, Mediastinal                            (48)         (11)         (49)         (11)         (47)         (10)         
      Atrophy                                          1 (2%)                                                                       
      Congestion                                                    1 (9%)                                              1 (10%)     
      Hemorrhage                                                                 3 (6%)                                             
      Hemorrhage, Acute                                1 (2%)                                                                       
      Hemorrhage, Chronic                              6 (13%)                                                                      
      Hyperplasia, Histiocytic                                                  40 (82%)      8 (73%)     43 (91%)      7 (70%)     
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
   Lymph Node, Mesenteric                             (49)         (10)         (48)         (15)         (47)         (10)         
      Atrophy                                          1 (2%)                                                                       
      Depletion Lymphoid                                            1 (10%)                                                         
      Hemorrhage                                                                 2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hemorrhage, Acute                                1 (2%)                                                                       
      Hyperplasia, Histiocytic                                                                2 (13%)                               
      Hyperplasia, Lymphoid                            1 (2%)       2 (20%)      2 (4%)                    3 (6%)                   
      Hyperplasia, Plasma Cell                                                                             1 (2%)                   
      Inflammation, Chronic Active                                                                         1 (2%)                   
   Spleen                                             (49)         (11)         (50)         (15)         (48)         (10)         
      Atrophy                                          1 (2%)                                              2 (4%)       1 (10%)     
      Autolysis                                                                                            1 (2%)                   
      Congestion, Acute                                             1 (9%)                                                          
      Congestion, Chronic                              1 (2%)                                                                       
      Cyst                                                                                                 1 (2%)                   
      Fibrosis                                                                   1 (2%)                                             
      Fibrosis, Focal                                                            5 (10%)                   2 (4%)                   
      Hematopoietic Cell Proliferation                 1 (2%)                    2 (4%)                    3 (6%)                   
      Hyperplasia, Histiocytic                                                   1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                    1 (2%)                   
      Infarct                                          3 (6%)                                 1 (7%)                                
      Inflammation, Focal, Granulomatous               1 (2%)                                              1 (2%)                   
   Thymus                                             (48)         (11)         (40)         (13)         (43)         (9)          
      Atrophy                                                       1 (9%)       2 (5%)                                             
      Cyst                                             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (45)         (10)         (48)         (11)         (50)         (9)          
      Galactocele                                      1 (2%)                                                                       
      Hyperplasia, Cystic                                                                     1 (9%)                                
      Lobules, Hyperplasia                                                                                              1 (11%)     
   Skin                                               (48)         (11)         (50)         (15)         (50)         (10)         
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Subcutaneous Tissue, Inflammation                                                                    1 (2%)                   
      Tail, Necrosis                                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (11)         (50)         (15)         (50)         (10)         
      Fibrous Osteodystrophy                           3 (6%)                    4 (8%)                    5 (10%)                  
      Coccygeal, Necrosis                              1 (2%)                                                                       
      Pelvis, Fracture                                                           1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (49)         (11)         (50)         (15)         (50)         (10)         
      Compression                                      5 (10%)                   2 (4%)                    2 (4%)                   
      Hemorrhage                                                                 1 (2%)                                             
      Infarct                                                                                              1 (2%)                   
      Necrosis, Focal                                  1 (2%)                    2 (4%)                                             
   Spinal Cord                                                                                            (1)                       
      Degeneration                                                                                         1 (100%)                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (48)         (11)         (49)         (15)         (49)         (10)         
      Inflammation, Suppurative                        6 (13%)                                                                      
   Lung                                               (49)         (11)         (50)         (15)         (50)         (10)         
      Congestion                                       1 (2%)                                                                       
      Crystals, Focal                                  1 (2%)                                                                       
      Cyst                                                                                                 3 (6%)                   
      Hemorrhage, Chronic                              2 (4%)                                                                       
      Infarct                                          1 (2%)                                                                       
      Inflammation, Granulomatous                      2 (4%)       1 (9%)      50 (100%)    15 (100%)    49 (98%)     10 (100%)    
      Inflammation, Suppurative                                                  2 (4%)                                             
      Mineralization                                                             4 (8%)                                             
      Alveolar Epithelium, Hyperplasia                 5 (10%)      1 (9%)      26 (52%)     12 (80%)     38 (76%)      7 (70%)     
      Alveolus, Hemorrhage, Focal                      1 (2%)                                                                       
      Alveolus, Metaplasia, Squamous                                                                       2 (4%)                   
      Artery, Thrombosis                               1 (2%)                                                                       
      Interstitium, Fibrosis, Focal                    1 (2%)                   16 (32%)     10 (67%)     33 (66%)      7 (70%)     
      Interstitium, Mineralization                     2 (4%)                    1 (2%)                    4 (8%)                   
      Peribronchial, Hyperplasia, Histiocytic                                   12 (24%)      4 (27%)      8 (16%)      5 (50%)     
   Nose                                               (49)         (11)         (48)         (15)         (47)         (10)         
      Inflammation, Suppurative                        2 (4%)       1 (9%)       1 (2%)                                             
      Lumen, Foreign Body                              1 (2%)                                                                       
      Lumen, Hemorrhage                                                                                    1 (2%)                   
      Mucosa, Inflammation, Suppurative                4 (8%)                    5 (10%)                   2 (4%)                   
      Nasolacrimal Duct, Inflammation, Suppurative                               1 (2%)                                             
      Respiratory Epithelium, Hyperplasia                                        3 (6%)                   14 (30%)      1 (10%)     
   Trachea                                            (49)         (11)         (50)         (15)         (48)         (10)         
      Inflammation, Suppurative                        3 (6%)                                              1 (2%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)                       (2)                       (2)                       
      Cataract                                         1 (33%)                   1 (50%)                   2 (100%)                 
      Inflammation, Chronic                                                                                1 (50%)                  
      Cornea, Inflammation, Necrotizing                                                                    1 (50%)                  
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05079-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                TALC                                           Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:10:44  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      CONTROL      6 MG/M3      6 MG/M3      18 MG/M3     18 MG/M3        
                                                                LUNG TOX                  LUNG TOX                  LUNG TOX        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Cornea, Necrosis                                 1 (33%)                                                                      
      Lens, Cataract                                   1 (33%)                                                                      
      Retina, Degeneration                             2 (67%)                   1 (50%)                   1 (50%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (11)         (49)         (15)         (48)         (10)         
      Calculus Micro Observation Only                                                                      1 (2%)                   
      Cyst                                             3 (6%)                                              1 (2%)                   
      Hydronephrosis                                                             1 (2%)                    1 (2%)                   
      Inflammation, Chronic                                         1 (9%)                                                          
      Nephropathy                                     45 (92%)      4 (36%)     47 (96%)      9 (60%)     43 (90%)      3 (30%)     
      Medulla, Inflammation                                                      1 (2%)                    1 (2%)                   
      Renal Tubule, Necrosis                                                     1 (2%)                                             
   Ureter                                                                                                 (1)                       
      Calculus Micro Observation Only                                                                      1 (100%)                 
   Urethra                                                                                                (1)                       
      Fibrosis                                                                                             1 (100%)                 
   Urinary Bladder                                    (49)         (11)         (48)         (15)         (47)         (9)          
      Calculus Gross Observation                                                                           1 (2%)                   
      Calculus Gross Observation, Single                            1 (9%)                                                          
      Calculus Micro Observation Only                                                         1 (7%)                                
      Inflammation                                     1 (2%)                                                                       
      Mucosa, Hyperplasia                                                                                  1 (2%)                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------